Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Higher leptin levels link to hair loss.

New treatment improves male hair loss.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Polysaccharides have many health benefits and are used in drugs, but isolating and purifying them is complex and requires careful methods.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Human skin can make serotonin and melatonin.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Current treatments for alopecia show no significant long-term benefits.